Light detection action: feasibility of ECL for the monitoring of therapeutic dosage toward personalised medicine

Research output: Contribution to conferencePoster

1 Downloads (Pure)

Abstract

Electrochemiluminescence (ECL) has a proven track record for the detection of illicit substances, yet little investigation into its application within medical devices has been witnessed to date. The ability to not only detect therapeutic products such as cancer therapies, but monitor these alongside disease biomarkers will provide the prognostic and diagnostic information required by physicians to begin to construct personalised treatment plans. Here we present an initial feasibility study toward the development of a remote ECL sensor for the monitoring of cancer therapy uptake alongside disease biomarkers to facilitate remote and real-time patient monitoring.
Original languageEnglish
Pages1
DOIs
Publication statusPublished - 2 Mar 2021
Event2021 #RSCPoster Twitter Conference - Virtual
Duration: 2 Mar 20213 Mar 2021
https://www.rsc.org/our-events/rsc-poster/

Conference

Conference2021 #RSCPoster Twitter Conference
Period2/03/213/03/21
Internet address

Keywords

  • electrochemiluminescence (ECL)
  • biomedical analysis
  • cancer research

Fingerprint Dive into the research topics of 'Light detection action: feasibility of ECL for the monitoring of therapeutic dosage toward personalised medicine'. Together they form a unique fingerprint.

Cite this